US equities |
MU $978.84 ▲+5.39% META $612.87 ▼-1.18% TSLA $403.35 ▼-1.01% SPCX $144.78 ▼-2.56% NVDA $216.17 ▼-0.81% SNDK $1,397.80 ▲+7.12% GOOGL $324.61 ▲+1.26% AMD $575.18 ▲+2.66%
FinancialContent

Articles published by Can-Fite BioPharma Ltd

News headline image
Can-Fite Expands its Phase II COVID-19 Study to Europe
From Can-Fite BioPharma Ltd
Via Business Wire
Tickers CANF